These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 26462866)

  • 1. Retinoic acid receptor β2 agonists restore glycaemic control in diabetes and reduce steatosis.
    Trasino SE; Tang XH; Jessurun J; Gudas LJ
    Diabetes Obes Metab; 2016 Feb; 18(2):142-51. PubMed ID: 26462866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease.
    Trasino SE; Tang XH; Jessurun J; Gudas LJ
    J Mol Med (Berl); 2016 Oct; 94(10):1143-1151. PubMed ID: 27271256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
    Komiya C; Tsuchiya K; Shiba K; Miyachi Y; Furuke S; Shimazu N; Yamaguchi S; Kanno K; Ogawa Y
    PLoS One; 2016; 11(3):e0151511. PubMed ID: 26977813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of loganin, iridoid glycoside from Corni Fructus, on hepatic and renal glucolipotoxicity and inflammation in type 2 diabetic db/db mice.
    Yamabe N; Noh JS; Park CH; Kang KS; Shibahara N; Tanaka T; Yokozawa T
    Eur J Pharmacol; 2010 Dec; 648(1-3):179-87. PubMed ID: 20826139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice.
    Liu S; Yuan J; Yue W; Bi Y; Shen X; Gao J; Xu X; Lu Z
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3257-3267. PubMed ID: 30006154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esculetin prevents non-alcoholic fatty liver in diabetic mice fed high-fat diet.
    Choi RY; Ham JR; Lee MK
    Chem Biol Interact; 2016 Dec; 260():13-21. PubMed ID: 27769711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease.
    Tang XH; Melis M; Lu C; Rappa A; Zhang T; Jessurun J; Gross SS; Gudas LJ
    J Biol Chem; 2021 Dec; 297(6):101331. PubMed ID: 34688661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of heat-treated Enterococcus faecalis FK-23 on high-fat diet-induced hepatic steatosis in mice.
    Kondoh M; Shimada T; Fukada K; Morita M; Katada K; Higashimura Y; Mizushima K; Okamori M; Naito Y; Yoshikawa T
    Br J Nutr; 2014 Sep; 112(6):868-75. PubMed ID: 25089585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nighttime Administration of Nicotine Improves Hepatic Glucose Metabolism via the Hypothalamic Orexin System in Mice.
    Tsuneki H; Nagata T; Fujita M; Kon K; Wu N; Takatsuki M; Yamaguchi K; Wada T; Nishijo H; Yanagisawa M; Sakurai T; Sasaoka T
    Endocrinology; 2016 Jan; 157(1):195-206. PubMed ID: 26492471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice.
    Kim HW; Lee JE; Cha JJ; Hyun YY; Kim JE; Lee MH; Song HK; Nam DH; Han JY; Han SY; Han KH; Kang YS; Cha DR
    Endocrinology; 2013 Sep; 154(9):3366-76. PubMed ID: 23825123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ghrelin receptor inverse agonists as a novel therapeutic approach against obesity-related metabolic disease.
    Abegg K; Bernasconi L; Hutter M; Whiting L; Pietra C; Giuliano C; Lutz TA; Riediger T
    Diabetes Obes Metab; 2017 Dec; 19(12):1740-1750. PubMed ID: 28544245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance.
    Wang XA; Zhang R; Zhang S; Deng S; Jiang D; Zhong J; Yang L; Wang T; Hong S; Guo S; She ZG; Zhang XD; Li H
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E485-95. PubMed ID: 23695216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiabetic effects of flavonoids from Sophora flavescens EtOAc extract in type 2 diabetic KK-ay mice.
    Yang X; Yang J; Xu C; Huang M; Zhou Q; Lv J; Ma X; Ke C; Ye Y; Shu G; Zhao P
    J Ethnopharmacol; 2015 Aug; 171():161-70. PubMed ID: 26051831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
    Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
    J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild ginseng cambial meristematic cells ameliorate hepatic steatosis and mitochondrial dysfunction in high-fat diet-fed mice.
    Lee SB; Cho HI; Jin YW; Lee EK; Ahn JY; Lee SM
    J Pharm Pharmacol; 2016 Jan; 68(1):119-27. PubMed ID: 26806698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Centaurium erythraea Rafn, Artemisia herba-alba Asso and Trigonella foenum-graecum L. on liver fat accumulation in C57BL/6J mice with high-fat diet-induced type 2 diabetes.
    Hamza N; Berke B; Cheze C; Marais S; Lorrain S; Abdouelfath A; Lassalle R; Carles D; Gin H; Moore N
    J Ethnopharmacol; 2015 Aug; 171():4-11. PubMed ID: 26023031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin increases hepatic leptin receptor and decreases steatosis in mice.
    Tang X; Li J; Xiang W; Cui Y; Xie B; Wang X; Xu Z; Gan L
    J Endocrinol; 2016 Aug; 230(2):227-37. PubMed ID: 27288055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease.
    Melis M; Tang XH; Trasino SE; Patel VM; Stummer DJ; Jessurun J; Gudas LJ
    PLoS One; 2019; 14(1):e0211071. PubMed ID: 30677086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.